-
Mashup Score: 10
Researchers say new yeast biosynthetic platform provides “vast opportunities” to produce structural variants of QS-21 and identify new adjuvant leads.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 9
New study suggests that a subset of cancers with high levels of PI3KR5 expression might respond better to an experimental immunotherapy.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 8Novo Nordisk, Flagship's Metaphore Launch Obesity Collaboration - 8 hour(s) ago
Novo Nordisk and Metaphore Biotechnologies will partner to develop obesity management treatments in an up-to-$600 million-plus collaboration.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 1
The Crick Institute plans to leverage Broken String’s DNA break-mapping platform to develop novel applications for ALS treatments.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 12ASGCT 2024: Mammoth Sizes Up Genome Editing Opportunities - 9 hour(s) ago
We catch up with Mammoth Biosciences CSO Lucas Harrington after his ASGCT presentation. Harrington lays out his company’s big plans in developing a range of therapeutic options using miniature Cas nucleases as well as the company’s recently disclosed alliance with Regeneron.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 31
Researchers say new yeast biosynthetic platform provides “vast opportunities” to produce structural variants of QS-21 and identify new adjuvant leads.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 29
New study suggests that a subset of cancers with high levels of PI3KR5 expression might respond better to an experimental immunotherapy.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 1Broken String-Crick Institute Collaboration Focuses on ALS Research - 12 hour(s) ago
The Crick Institute plans to leverage Broken String’s DNA break-mapping platform to develop novel applications for ALS treatments.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 3
Internal neural compass which the human brain uses to orientate itself in space and navigate through the environment has been identified.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 1
Solvias says its new center complements its biologics and CGT sites in Europe and expands its testing capabilities in the United States.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
Vaccine Adjuvant from Tree Bark Has Been Produced by Engineered Yeast Researchers say new yeast biosynthetic platform provides "vast opportunities" to produce structural variants of QS-21 and identify new adjuvant leads. Learn more: https://t.co/1H4jQeScSF https://t.co/egVdHo1zNE